Navigation Links
MultiVu Video Feed: FREE NICOTINE REPLACEMENT THERAPY (NRT) TO BE OFFERED TO REGISTERED PILOTS INTERESTED IN QUITTING RELIEF IN LIGHT OF RECENT FAA RULINGS
Date:5/23/2008

COMMIT LOZENGE CAN HELP REVERSE MENTAL ACUITY DEFICITS IN SMOKERS WHO ARE QUITTING PLUS: Medical Expert Available for Interview to Address FAA Ruling on Smoking Cessation Product

In light of the recent announcement by the Federal Aviation Administration (FAA) that it has removed a prescription anti-smoking pill from their approved list of safe medications for pilots and air-traffic controllers, it's important to note this news does not include NRT, which is deemed safe and effective. GlaxoSmithKline Consumer Healthcare, industry leaders in smoking cessation, is offering one free 48 count carton of Commit lozenges to all licensed commercial and private pilots now through June 30. The product can be requested by calling 1.877.NOASHES, or 1.877.662.7437, callers will also have the opportunity to speak to a trained smoking cessation counselor.

Research has found the Commit 4 mg lozenge has been clinically shown to help reverse nicotine withdrawal symptoms associated with quitting smoking, including the following: difficulty concentrating, attention deficit, short-term memory deficit and selective attention deficit - issues at the core of the FAA's report.

Jack Henningfield, Ph.D., is one of the world's leading experts on nicotine addiction, and served on the expert panel the FAA requested the Centers for Disease Control (CDC) assemble in 1994 to examine the effects of smoking and tobacco addiction and withdrawal on pilot performance and airline safety. As part of the panel's conclusion, they made recommendations for safe, effective treatment options for pilots who smoke. Dr. Henningfield will be available for interview via satellite on Friday, May 23rd to discuss the FAA's announcement.

SATELLITE FEEDS:

Friday, May 23rd, 2008 Friday, May 23rd, 2008

3:30 PM - 3:45 PM ET 6:30 PM - 6:45 PM ET

Galaxy 26 Galaxy 26

C-Band C-Band

Transponder 18 Transponder 18

Downlink Freq. 4060 Horizontal Downlink Freq. 4060 Horizontal

Saturday, May 24th, 2008

1:30 PM - 1:45 PM ET

Galaxy 26

C-Band

Transponder 18

Downlink Freq. 4060 Horizontal

NEWS: GSK TO OFFER FREE COMMIT LOZENGES TO ALL LICENSED PILOTS INTERESTED IN QUITTING NOW THROUGH JUNE 30

FORMAT: B-roll and Soundbites

ADDITIONAL RESOURCES: Video, contact information and more available at: http://www.prnewswire.com/broadcast/33418/press.html

SOUNDBITES:

* Jack Henningfield, Ph.D., one of the world's leading experts on

nicotine addiction

B-ROLL INCLUDES:

* General street scenes of people smoking

* General footage of "no smoking" signs at bars/restaurants, cigarettes,

etc.

* Nicotine replacement therapy product shots

* Applying patch to the skin/use of oral forms (gum/lozenge)

VIDEO PROVIDED BY: GlaxoSmithKline Consumer Healthcare

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3


'/>"/>
SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MultiVu Video Feed: Richard Simmons and Ocean Spray Team-Up to Solve
2. MultiVu Video Feed: Podiatrists Keep America Walking
3. MultiVu Video Feed: Stinky Sneakers Worth Big Money!
4. MultiVu Video Feed: New National Colorectal Cancer Screening Guidelines Issued by the American Cancer Society
5. MultiVu Video Feed: LIFE AND STYLE EXPERT SANDRA LEE OFFERS RECIPES AND SHORTCUTS IN THE KITCHEN TO PEOPLE WITH RHEUMATOID ARTHRITIS
6. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
7. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
8. MultiVu Video Feed: NEW SURVEY FINDS THAT HALF OF CAREGIVERS SPEND 10 PERCENT OF THEIR INCOME CARING FOR AN OLDER LOVED ONE
9. MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS
10. MultiVu Video Feed: Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With "Silence the Sounds of Pertussis" Campaign
11. MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: